206 related articles for article (PubMed ID: 9347277)
41. Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation.
Zapolski T; Wysokiński A
Kardiol Pol; 2005 Sep; 63(3):254-62; discussion 263-4. PubMed ID: 16180181
[TBL] [Abstract][Full Text] [Related]
42. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
Alboni P; Botto GL; Baldi N
Ital Heart J Suppl; 2005 Jun; 6(6):335-40. PubMed ID: 16013424
[TBL] [Abstract][Full Text] [Related]
43. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
44. Clinical comparison of ibutilide and propafenone for converting atrial flutter.
Sun JL; Guo JH; Zhang N; Zhang HC; Zhang P
Cardiovasc Drugs Ther; 2005 Jan; 19(1):57-64. PubMed ID: 15883757
[TBL] [Abstract][Full Text] [Related]
45. Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment.
Boriani G; Martignani C; Biffi M; Capucci A; Branzi A
Drugs; 2002; 62(3):415-23. PubMed ID: 11827557
[TBL] [Abstract][Full Text] [Related]
46. Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine.
Lau CP; Chow MS; Tse HF; Tang MO; Fan C
Am J Cardiol; 2000 Dec; 86(12):1327-32. PubMed ID: 11113407
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: a placebo-controlled study.
Bellandi F; Cantini F; Pedone T; Palchetti R; Bamoshmoosh M; Dabizzi RP
Clin Cardiol; 1995 Nov; 18(11):631-4. PubMed ID: 8590531
[TBL] [Abstract][Full Text] [Related]
48. Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study.
Kochiadakis GE; Igoumenidis NE; Parthenakis FI; Chlouverakis GI; Vardas PE
J Am Coll Cardiol; 1999 Mar; 33(4):966-71. PubMed ID: 10091823
[TBL] [Abstract][Full Text] [Related]
49. [Comparison of efficacy, safety and cost-effectiveness of intravenous versus oral propafenone in paroxysmal atrial fibrillation].
Zadura M; Grossmann G; Modrzewska A; Klecha T; Klepacka H; Rumiński W
Pol Merkur Lekarski; 2001 Aug; 11(62):137-9. PubMed ID: 11757212
[TBL] [Abstract][Full Text] [Related]
50. Reproducible efficacy of loading oral propafenone in restoring sinus rhythm in patients with paroxysmal atrial fibrillation.
Capucci A; Villani GQ; Piepoli MF
Am J Cardiol; 2003 Dec; 92(11):1345-7. PubMed ID: 14636919
[TBL] [Abstract][Full Text] [Related]
51. Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
Alboni P; Botto GL; Boriani G; Russo G; Pacchioni F; Iori M; Pasanisi G; Mancini M; Mariconti B; Capucci A
Heart; 2010 Apr; 96(7):546-9. PubMed ID: 20350992
[TBL] [Abstract][Full Text] [Related]
52. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
53. Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
Conde D; Costabel JP; Aragon M; Lambardi F; Klein A; Corrales Barbosa A; Trivi M; Giniger A
Cardiovasc Ther; 2013 Dec; 31(6):377-80. PubMed ID: 23683253
[TBL] [Abstract][Full Text] [Related]
54. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
Suttorp MJ; Kingma JH; Jessurun ER; Lie-A-Huen L; van Hemel NM; Lie KI
J Am Coll Cardiol; 1990 Dec; 16(7):1722-7. PubMed ID: 2123909
[TBL] [Abstract][Full Text] [Related]
55. Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses.
Kochiadakis GE; Igoumenidis NE; Hamilos MI; Tzerakis PG; Klapsinos NC; Zacharis EA; Vardas PE
Chest; 2004 Feb; 125(2):377-83. PubMed ID: 14769712
[TBL] [Abstract][Full Text] [Related]
56. Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery.
Geelen P; O'Hara GE; Roy N; Talajic M; Roy D; Plante S; Turgeon J
Am J Cardiol; 1999 Aug; 84(3):345-7, A8-9. PubMed ID: 10496451
[TBL] [Abstract][Full Text] [Related]
57. Propafenone in the conversion of atrial fibrillation in patients suffering from chronic renal failure.
Napoli C; Sorice P; Di Benedetto A; Di Ieso N; Liguori A
Am J Ther; 1997 Apr; 4(4):130-3. PubMed ID: 10423602
[TBL] [Abstract][Full Text] [Related]
58. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study.
Kochiadakis GE; Igoumenidis NE; Simantirakis EN; Marketou ME; Parthenakis FI; Mezilis NE; Vardas PE
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2475-9. PubMed ID: 9825370
[TBL] [Abstract][Full Text] [Related]
59. Combined administration of quinidine and propafenone for atrial fibrillation: the CAQ-PAF study.
O'Hara GE; Philippon F; Gilbert M; Champagne J; Michaud V; Charbonneau L; Pruneau G; Hamelin BA; Geelen P; Turgeon J
J Clin Pharmacol; 2012 Feb; 52(2):171-9. PubMed ID: 21508180
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
Meinertz T; Lip GY; Lombardi F; Sadowski ZP; Kalsch B; Camez A; Hewkin A; Eberle S;
Am J Cardiol; 2002 Dec; 90(12):1300-6. PubMed ID: 12480038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
